Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

The artiodactyl APOBEC3 innate immune repertoire shows evidence for a multi-functional domain organization that existed in the ancestor of placental mammals.

LaRue RS, Jónsson SR, Silverstein KA, Lajoie M, Bertrand D, El-Mabrouk N, Hötzel I, Andrésdóttir V, Smith TP, Harris RS.

BMC Mol Biol. 2008 Nov 18;9:104. doi: 10.1186/1471-2199-9-104.

2.

Guidelines for naming nonprimate APOBEC3 genes and proteins.

LaRue RS, Andrésdóttir V, Blanchard Y, Conticello SG, Derse D, Emerman M, Greene WC, Jónsson SR, Landau NR, Löchelt M, Malik HS, Malim MH, Münk C, O'Brien SJ, Pathak VK, Strebel K, Wain-Hobson S, Yu XF, Yuhki N, Harris RS.

J Virol. 2009 Jan;83(2):494-7. doi: 10.1128/JVI.01976-08. No abstract available.

3.

Murine APOBEC1 is a powerful mutator of retroviral and cellular RNA in vitro and in vivo.

Petit V, Guétard D, Renard M, Keriel A, Sitbon M, Wain-Hobson S, Vartanian JP.

J Mol Biol. 2009 Jan 9;385(1):65-78. doi: 10.1016/j.jmb.2008.10.043.

PMID:
18983852
4.

Crystal structure of the anti-viral APOBEC3G catalytic domain and functional implications.

Holden LG, Prochnow C, Chang YP, Bransteitter R, Chelico L, Sen U, Stevens RC, Goodman MF, Chen XS.

Nature. 2008 Nov 6;456(7218):121-4. doi: 10.1038/nature07357.

5.

Organ-specific profiles of genetic changes in cancers caused by activation-induced cytidine deaminase expression.

Morisawa T, Marusawa H, Ueda Y, Iwai A, Okazaki IM, Honjo T, Chiba T.

Int J Cancer. 2008 Dec 15;123(12):2735-40. doi: 10.1002/ijc.23853.

6.

Antiretroelement activity of APOBEC3H was lost twice in recent human evolution.

OhAinle M, Kerns JA, Li MM, Malik HS, Emerman M.

Cell Host Microbe. 2008 Sep 11;4(3):249-59. doi: 10.1016/j.chom.2008.07.005.

7.

Activation-induced cytidine deaminase links between inflammation and the development of colitis-associated colorectal cancers.

Endo Y, Marusawa H, Kou T, Nakase H, Fujii S, Fujimori T, Kinoshita K, Honjo T, Chiba T.

Gastroenterology. 2008 Sep;135(3):889-98, 898.e1-3. doi: 10.1053/j.gastro.2008.06.091.

PMID:
18691581
8.

Two regions within the amino-terminal half of APOBEC3G cooperate to determine cytoplasmic localization.

Stenglein MD, Matsuo H, Harris RS.

J Virol. 2008 Oct;82(19):9591-9. doi: 10.1128/JVI.02471-07.

9.

Functional domain organization of human APOBEC3G.

Gooch BD, Cullen BR.

Virology. 2008 Sep 15;379(1):118-24. doi: 10.1016/j.virol.2008.06.013.

10.

Evidence for editing of human papillomavirus DNA by APOBEC3 in benign and precancerous lesions.

Vartanian JP, Guétard D, Henry M, Wain-Hobson S.

Science. 2008 Apr 11;320(5873):230-3. doi: 10.1126/science.1153201.

11.

Functions, structure, and read-through alternative splicing of feline APOBEC3 genes.

Münk C, Beck T, Zielonka J, Hotz-Wagenblatt A, Chareza S, Battenberg M, Thielebein J, Cichutek K, Bravo IG, O'Brien SJ, Löchelt M, Yuhki N.

Genome Biol. 2008;9(3):R48. doi: 10.1186/gb-2008-9-3-r48.

12.

The DNA deaminase activity of human APOBEC3G is required for Ty1, MusD, and human immunodeficiency virus type 1 restriction.

Schumacher AJ, Haché G, Macduff DA, Brown WL, Harris RS.

J Virol. 2008 Mar;82(6):2652-60. doi: 10.1128/JVI.02391-07.

13.

Role of APOBEC3 in genetic diversity among endogenous murine leukemia viruses.

Jern P, Stoye JP, Coffin JM.

PLoS Genet. 2007 Oct;3(10):2014-22.

14.
15.

Population stratification of a common APOBEC gene deletion polymorphism.

Kidd JM, Newman TL, Tuzun E, Kaul R, Eichler EE.

PLoS Genet. 2007 Apr 20;3(4):e63.

16.

Expression of activation-induced cytidine deaminase in human hepatocytes via NF-kappaB signaling.

Endo Y, Marusawa H, Kinoshita K, Morisawa T, Sakurai T, Okazaki IM, Watashi K, Shimotohno K, Honjo T, Chiba T.

Oncogene. 2007 Aug 16;26(38):5587-95.

PMID:
17404578
17.

Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium.

Matsumoto Y, Marusawa H, Kinoshita K, Endo Y, Kou T, Morisawa T, Azuma T, Okazaki IM, Honjo T, Chiba T.

Nat Med. 2007 Apr;13(4):470-6.

PMID:
17401375
18.
19.

Dual effect of APOBEC3G on Hepatitis B virus.

Noguchi C, Hiraga N, Mori N, Tsuge M, Imamura M, Takahashi S, Fujimoto Y, Ochi H, Abe H, Maekawa T, Yatsuji H, Shirakawa K, Takaori-Kondo A, Chayama K.

J Gen Virol. 2007 Feb;88(Pt 2):432-40.

PMID:
17251560
20.

N-terminal and C-terminal cytosine deaminase domain of APOBEC3G inhibit hepatitis B virus replication.

Lei YC, Tian YJ, Ding HH, Wang BJ, Yang Y, Hao YH, Zhao XP, Lu MJ, Gong FL, Yang DL.

World J Gastroenterol. 2006 Dec 14;12(46):7488-96.

Items per page

Supplemental Content

Support Center